IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today ...
TUSTIN, Calif., Nov. 1, 2024 /PRNewswire/ -- Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic imaging services, to bring the ...
IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader in ...
TUSTIN, Calif., May 16, 2025 /PRNewswire/ -- Pangea Laboratory, a leader in the development of advanced cancer diagnostics and microbiome Next-Generation Sequencing (NGS) testing, is proud to announce ...
TUSTIN, Calif., Dec. 20, 2023 /PRNewswire/ -- Pangea Laboratory has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its non-invasive Bladder CARE™ Assay, ...
Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, has announced a strategic collaboration with Gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results